Adecto Pharmaceuticals
Adecto Pharmaceuticals is a pre-clinical stage, cancer therapeutics company, developing the first targeted therapy against aggressive ADAM8-positive cancers and a companion diagnostic to identify patients who can benefit from it. It is the culmination of over 30 years of research hunting down molecules that can be safely targeted to stop both primary cancer growth and metastases.
Company Ownership:
Woman Owned
Contact Name:
Nora Mineva
Contact Email:
Website:
https://www.adectopharma.com
City, State – Congressional District:
Brookline,
MA
–
7
Technology:
Drug
Funding:
Cancer (NCI)
NIH Projects:
NIH RePorter for
Adecto Pharmaceuticals
Sponsored Event(s):
BIO | 2021
